U.S. Markets open in 7 hrs 39 mins

DEADLINE ALERT -- Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX) & Lead Plaintiff Deadline - December 3, 2018

NEW YORK, NY / ACCESSWIRE / November 29, 2018 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against TG Therapeutics, Inc. ("TG Therapeutics" or the "Company") (TGTX) on behalf of shareholders who purchased or otherwise acquired TG Therapeutics securities between June 4, 2018 and September 25, 2018, (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/tgtx.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information about the Company. Specifically, the complaint alleges that defendants: (1) deceived the investing public regarding TG's prospects and business; (2) artificially inflated the price of TG common stock; and (3) caused plaintiff and other members of the Class to purchase TG common stock at inflated prices.

On September 26, 2018, TG Therapeutics revealed that it could not proceed with the interim analysis of UNITY-CLL as a result of the Data Safety Monitoring Board trials, and that these trials determined that the data was not mature enough to continue. Following this news, TG Therapeutics dropped 44% to close at $5.15 per share.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/tgtx or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in TG Therapeuticsyou can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.


Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC